Vyome Therapeutics Strengthens Executive Management with Appointment of Craig Tooman as Chief Operating Officer and Chief Financial Officer
January 07, 2020 07:30 ET
|
Vyome Therapeutics Inc.
PRINCETON, N.J., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage company developing locally-acting, next generation therapeutics for inflammatory diseases, today announced the...
Vyome Therapeutics Completes Enrollment of Phase 2 Clinical Trial with VB-1953 in Moderate to Severe Inflammatory Acne
November 05, 2019 07:30 ET
|
Vyome Therapeutics Inc.
PRINCETON, N.J., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant...
Vyome Therapeutics Presents Positive Results from Two Key Clinical Trials at the 2019 Society for Investigative Dermatology Annual Meeting
May 13, 2019 07:30 ET
|
Vyome Therapeutics Inc.
PRINCETON, N.J., May 13, 2019 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant...
Vyome Therapeutics to Present Clinical Data on VB-1953 at the 2019 Society for Investigative Dermatology Annual Meeting
May 07, 2019 07:30 ET
|
Vyome Therapeutics Inc.
PRINCETON, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- Vyome Therapeutics, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant...
Vyome Therapeutics Begins Dosing in Phase 2 Trial of VB-1953 in Moderate to Severe Inflammatory Acne Vulgaris
April 23, 2019 07:30 ET
|
Vyome Therapeutics Inc.
PRINCETON, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Vyome Therapeutics Inc., a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by...
Vyome raises $22M to advance dermatology pipeline
January 03, 2019 06:00 ET
|
Vyome Biosciences Private Limited
PRINCETON, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Vyome Therapeutics Inc., a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by...
Vyome Biosciences Presents Two Novel Treatments for Drug-Resistant Skin Microbes at the International Investigative Dermatology 2018 Meeting
May 17, 2018 16:00 ET
|
Vyome Biosciences Private Limited
NEW DELHI, India, May 17, 2018 (GLOBE NEWSWIRE) -- Vyome Biosciences, a clinical-stage company developing novel treatments for skin diseases caused by resistant microbes, today announced two poster...
Vyome Biosciences to Present at The Cowen and Company 38th Annual Health Care Conference
March 12, 2018 16:01 ET
|
Vyome Biosciences Private Limited
NEW DELHI, India, March 12, 2018 (GLOBE NEWSWIRE) -- Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant...
Vyome Biosciences Announces Launch of Dermatology Products Through Exclusive Partnership
February 26, 2018 08:30 ET
|
Vyome Biosciences Private Limited
Vyome Partners with a Large, Global Specialty Pharmaceutical Company to Market its Dandruff Products NEW DELHI, India, Feb. 26, 2018 (GLOBE NEWSWIRE) -- Vyome Biosciences, a clinical-stage...
Vyome Biosciences Appoints Dr. Charles G. Chavdarian Senior Vice President of Product Development and Regulatory CMC
November 13, 2017 08:00 ET
|
Vyome Biosciences Private Limited
Dr. Chavdarian brings over 30 years of novel product development and regulatory experience to the role NEW DELHI, India, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Vyome Biosciences, a clinical-stage...